Projected Saudi Arabian pediatric emergency consultant physician staffing needs for 2021-2030

Areej Abudan1, Olesya Baker2, Amal Yousif3

  • 1Saudi Ministry of Health Riyadh Saudi Arabia.

Insights

Saudi Arabia faces a growing deficit in pediatric emergency physicians, with demand projected to significantly outstrip supply by 2030. This impacts the care of children in emergency departments (EDs).

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Workforce Planning
  • Public Health Policy

Background:

  • Assessing pediatric emergency physician needs in Saudi Arabia from 2021 to 2030.
  • Focus on 26 pediatric emergency departments across 10 administrative regions.

Purpose of the Study:

  • To evaluate the current and future supply and demand of pediatric emergency physicians.
  • To identify potential workforce shortages in pediatric emergency care.

Main Methods:

  • Utilized time series linear regression modeling based on 2015-2019 data.
  • Estimated pediatric population, emergency department visits, and physician needs.
  • Calculated physician deficits using a Saudi Ministry of Health consensus method.

Main Results:

  • Projected pediatric population to reach 9.7 million by 2030.
  • Estimated over 4.6 million pediatric emergency visits by 2030.
  • Anticipated a deficit of 1405 pediatric emergency physicians by 2030.

Conclusions:

  • Significant disparity exists between pediatric emergency physician supply and demand in Saudi Arabia.
  • Urgent workforce planning is required to address projected shortages.
  • Ensuring adequate pediatric emergency care necessitates proactive measures.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Current Trends in Nursing I01:28

Current Trends in Nursing I

Current trends in nursing include:
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17